← Back to Search

Fitbit + Game + Support from a Teammate for Gynecologic Cancers (SISTERS Trial)

N/A
Waitlist Available
Led By Alexi A Wright, MD, MPH
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients ≥18 years of age with a gynecologic cancer (ovarian, fallopian tube, primary peritoneal carcinoma, uterine, or cervical) who have completed cancer treatment ≥ 6 weeks prior.
Own a smartphone (Android or iOS).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

SISTERS Trial Summary

This trial will help researchers understand if this type of mobile health intervention can work for this population.

SISTERS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

SISTERS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Burden Rate
Rate of Activity
Rate of Completion
+1 more

SISTERS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Fitbit + Game + Support from a TeammateExperimental Treatment1 Intervention
After the screening procedures confirm participation in the research study. Participants randomized into Fitbit + Game + Support from a Teammate. Participants will select a step goal, use a Fitbit to track daily activity, and select a teammate (e.g. family member or friend) who they think will help them achieve their goals. Participants will participate a 3-month game designed to increase activity and then followed for another 1.5 months to see if their increased activity can be maintained without the game. The study interventions involved in this research are: Fitbit (also known as a wearable accelerometer or fitness tracker) Help from a Teammate (i.e. friend or family member chosen to help reach goals, if applicable Way to Health Platform Surveys/Interviews
Group II: FitbitActive Control1 Intervention
After the screening procedures confirm participation in the research study. Participants randomized into Fitbit only group. -- Participants will track their daily steps for 4.5 months with use of a Fitbit The study interventions involved in this research are: Fitbit (also known as a wearable accelerometer or fitness tracker) Way to Health platform Surveys/Interviews

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,072 Previous Clinical Trials
340,385 Total Patients Enrolled
7 Trials studying Gynecologic Cancers
26,082 Patients Enrolled for Gynecologic Cancers
Alexi A Wright, MD, MPHPrincipal InvestigatorDana-Farber Cancer Institute
2 Previous Clinical Trials
170 Total Patients Enrolled
1 Trials studying Gynecologic Cancers
121 Patients Enrolled for Gynecologic Cancers

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are eligible to join this research endeavor?

"To complete this research, 50 eligible candidates are sought. These participants can come from either Northern Light Cancer Care in Brewer, Maine or Lifespan Comprehensive Cancer Center in Providence, Rhode island and other approved sites."

Answered by AI

Are there any available positions remaining in this research trial?

"Affirmative. The information available on clinicaltrials.gov confirms that this research endeavour, initially advertised on January 29th 2021 is actively searching for participants. In total, 50 individuals must be enrolled at 3 separate medical institutions."

Answered by AI
~5 spots leftby Mar 2025